Annual Short Term Debt
$4.34 M
-$1.71 M-28.22%
December 31, 2023
Summary
- As of February 7, 2025, AMPH annual short term debt is $4.34 million, with the most recent change of -$1.71 million (-28.22%) on December 31, 2023.
- During the last 3 years, AMPH annual short term debt has fallen by -$11.28 million (-72.20%).
- AMPH annual short term debt is now -80.36% below its all-time high of $22.10 million, reached on December 31, 2013.
Performance
AMPH Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$4.46 M
+$216.00 K+5.09%
September 30, 2024
Summary
- As of February 7, 2025, AMPH quarterly short term debt is $4.46 million, with the most recent change of +$216.00 thousand (+5.09%) on September 30, 2024.
- Over the past year, AMPH quarterly short term debt has increased by +$309.00 thousand (+7.44%).
- AMPH quarterly short term debt is now -86.01% below its all-time high of $31.89 million, reached on March 31, 2014.
Performance
AMPH Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
AMPH Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -28.2% | +7.4% |
3 y3 years | -72.2% | -13.5% |
5 y5 years | -76.2% | -55.6% |
AMPH Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -28.2% | at low | -72.2% | +7.4% |
5 y | 5-year | -72.2% | at low | -72.2% | +7.4% |
alltime | all time | -80.4% | at low | -86.0% | +7.4% |
Amphastar Pharmaceuticals Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $4.46 M(+5.1%) |
Jun 2024 | - | $4.25 M(-2.9%) |
Mar 2024 | - | $4.37 M(+0.6%) |
Dec 2023 | $4.34 M(-28.2%) | $4.34 M(+4.6%) |
Sep 2023 | - | $4.15 M(-74.1%) |
Jun 2023 | - | $16.05 M(+211.2%) |
Mar 2023 | - | $5.16 M(-14.7%) |
Dec 2022 | $6.05 M(+16.7%) | $6.05 M(+24.4%) |
Sep 2022 | - | $4.86 M(-9.5%) |
Jun 2022 | - | $5.37 M(-1.2%) |
Mar 2022 | - | $5.44 M(+4.9%) |
Dec 2021 | $5.18 M(-66.8%) | $5.18 M(+1.3%) |
Sep 2021 | - | $5.12 M(-54.8%) |
Jun 2021 | - | $11.31 M(-28.7%) |
Mar 2021 | - | $15.88 M(+1.6%) |
Dec 2020 | $15.62 M(+43.1%) | $15.62 M(-1.2%) |
Sep 2020 | - | $15.81 M(+1.6%) |
Jun 2020 | - | $15.56 M(+4.1%) |
Mar 2020 | - | $14.94 M(+36.9%) |
Dec 2019 | $10.92 M | $10.92 M(+8.5%) |
Sep 2019 | - | $10.06 M(+3.9%) |
Jun 2019 | - | $9.68 M(-52.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $20.15 M(+10.5%) |
Dec 2018 | $18.23 M(+188.8%) | $18.23 M(-2.0%) |
Sep 2018 | - | $18.59 M(-1.6%) |
Jun 2018 | - | $18.89 M(+211.7%) |
Mar 2018 | - | $6.06 M(-4.0%) |
Dec 2017 | $6.31 M(+17.6%) | $6.31 M(+1.6%) |
Sep 2017 | - | $6.21 M(+0.1%) |
Jun 2017 | - | $6.21 M(+17.9%) |
Mar 2017 | - | $5.26 M(-1.9%) |
Dec 2016 | $5.37 M(-50.9%) | $5.37 M(-37.2%) |
Sep 2016 | - | $8.54 M(-21.7%) |
Jun 2016 | - | $10.90 M(-2.4%) |
Mar 2016 | - | $11.18 M(+2.2%) |
Dec 2015 | $10.93 M(+44.0%) | $10.93 M(-25.9%) |
Sep 2015 | - | $14.76 M(+16.9%) |
Jun 2015 | - | $12.63 M(+0.8%) |
Mar 2015 | - | $12.53 M(+65.0%) |
Dec 2014 | $7.59 M(-65.6%) | $7.59 M(-24.6%) |
Sep 2014 | - | $10.08 M(-5.5%) |
Jun 2014 | - | $10.66 M(-66.6%) |
Mar 2014 | - | $31.89 M(+44.3%) |
Dec 2013 | $22.10 M(+0.2%) | $22.10 M |
Dec 2012 | $22.05 M | - |
FAQ
- What is Amphastar Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual short term debt year-on-year change?
- What is Amphastar Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly short term debt year-on-year change?
What is Amphastar Pharmaceuticals annual short term debt?
The current annual short term debt of AMPH is $4.34 M
What is the all time high annual short term debt for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual short term debt is $22.10 M
What is Amphastar Pharmaceuticals annual short term debt year-on-year change?
Over the past year, AMPH annual short term debt has changed by -$1.71 M (-28.22%)
What is Amphastar Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of AMPH is $4.46 M
What is the all time high quarterly short term debt for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly short term debt is $31.89 M
What is Amphastar Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, AMPH quarterly short term debt has changed by +$309.00 K (+7.44%)